Radiopharm Theranostics Ltd (RAD) — Tangible Net Worth Ratio
Radiopharm Theranostics Ltd (RAD) has a Tangible Net Worth Ratio of 100.0% as of June 2026. This metric is calculated by deducting intangible assets (AU$0.00) from net assets (AU$22.32 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore RAD net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Radiopharm Theranostics Ltd Tangible Net Worth Ratio (2022–2026)
This chart shows how Radiopharm Theranostics Ltd's Tangible Net Worth Ratio has changed across 5 annual periods from 2022 to 2026. As of June 2026, the ratio stands at 100.0%, reflecting net assets of AU$22.32 Million with intangible assets of AU$0.00 AUD. For live market cap and overall valuation, see RAD company net worth.
Annual Tangible Net Worth Ratio for Radiopharm Theranostics Ltd (2022–2026)
The table below presents the year-by-year Tangible Net Worth Ratio for Radiopharm Theranostics Ltd from 2022 to 2026, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See RAD financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Tangible NW Ratio | Net Assets (AUD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2026 | 100.0% | AU$22.32 Million | AU$0.00 | AU$60.13 Million | ▲ +108.6 pp |
| 2025 | -8.6% | AU$42.87 Million | AU$46.57 Million | AU$86.48 Million | ▲ +70.8 pp |
| 2024 | -79.5% | AU$27.35 Million | AU$49.09 Million | AU$72.04 Million | ▼ -51.0 pp |
| 2023 | -28.4% | AU$45.58 Million | AU$58.54 Million | AU$74.95 Million | ▼ -39.4 pp |
| 2022 | 10.9% | AU$62.96 Million | AU$56.08 Million | AU$83.38 Million | — |